Clinical Trial Update: Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing systemic exposure of Primatene Mist via oral inhalation to epinephrine IM injection and ProAir via oral inhalation in healthy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Asthma

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)
• PRIMATENE MIST (EPINEPHRINE INHALATION)
• ProAir

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Pharmacokinetics, Epinephrine | Phase 4 | Status: COMPLETED | Results posted: 2021-03-30